Literature DB >> 21909901

[Arterial occlusive disease. Catheter-directed thrombolytic therapy].

C Stelzner1, R Langhoff.   

Abstract

Local catheter-directed thrombolysis of extremity artery or bypass thromboembolic occlusions is a promising therapeutic option with comparatively low complication rates, if the severity of the ischemia does not require urgent surgical revascularization. This therapeutic decision has to be made by a vascular team taking individual circumstances and contraindications into consideration. Apart from an adequate dosage, a strict intrathrombotic administration of the fibrinolytic agent and careful clinical monitoring including surveillance of the coagulation system is necessary and intensive care unit resources should be used. If necessary the thrombolysis therapy can be combined with mechanical thrombaspiration and balloon dilatation or surgical correction of an underlying lesion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21909901     DOI: 10.1007/s00108-011-2867-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  18 in total

1.  A systematic review of intra-arterial thrombolytic therapy for lower-limb ischaemia.

Authors:  S J Palfreyman; A Booth; J A Michaels
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-02       Impact factor: 7.069

Review 2.  [Medicamentous thrombolysis in acute occlusions of extremity arteries].

Authors:  T Kittner; C Stelzner
Journal:  Radiologe       Date:  2008-08       Impact factor: 0.635

3.  Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis--APART trial.

Authors:  Gunnar Tepe; Claudius Hopfenzitz; Klaus Dietz; Jakub Wiskirchen; Stephan Heller; Kenneth Ouriel; Gerhard Ziemer; Claus D Claussen; Stephan H Duda
Journal:  Radiology       Date:  2006-04-26       Impact factor: 11.105

4.  A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.

Authors:  K Ouriel; F J Veith; A A Sasahara
Journal:  N Engl J Med       Date:  1998-04-16       Impact factor: 91.245

5.  A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia.

Authors:  K Ouriel; C K Shortell; J A DeWeese; R M Green; C W Francis; M V Azodo; O H Gutierrez; J V Manzione; C Cox; V J Marder
Journal:  J Vasc Surg       Date:  1994-06       Impact factor: 4.268

6.  Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial.

Authors: 
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

7.  Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Michael Sobel; Raymond Verhaeghe
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 8.  Thrombolytic therapy in peripheral arterial disease.

Authors:  D Giannini; A Balbarini
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2004-09

9.  Reteplase monotherapy and reteplase/abciximab combination therapy in peripheral arterial occlusive disease: results from the RELAX trial.

Authors:  Kenneth Ouriel; Flavio Castaneda; Thomas McNamara; James Swischuk; Gunnar Tepe; John J Smith; Jason Clark; Stephan Duda
Journal:  J Vasc Interv Radiol       Date:  2004-03       Impact factor: 3.464

10.  Percutaneous intraarterial thrombolysis: analysis of factors affecting outcome.

Authors:  M E Clouse; K R Stokes; L J Perry; H G Wheeler
Journal:  J Vasc Interv Radiol       Date:  1994 Jan-Feb       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.